MBI Deep Dives

MBI Deep Dives

August, 2024 Update

Just a few quick updates for this month: 1. While I said last month that I would like to cover another healthcare company in August, I have changed my mind and would rather do a Deep Dive on EssilorLuxottica. Considering they may be an interesting piece of the value chain

Amazon 2Q'24 Update

Disclosure: I own Jan 2025 $55 call options of Amazon Now that all the big tech reported their quarters, we now have better context to how their quarters went. So, while I will mostly discuss Amazon's earnings in this update, I will briefly touch on some broader themes

Meta 2Q'24 Update

Disclosure: I own shares of Meta Platforms While the meme of “nobody uses Facebook” sort of evolved to “only old people use Facebook”, Meta reminded us that it’s just another urban myth: “…The growth we're seeing here in the U.S. has especially been a bright spot.

Alphabet 2Q'24 Update

Yesterday’s Google’s earnings may have been bit of “meh” at first glance, but there were nuggets in the call that may have important implications for the broader market. Here’s my highlights from the earnings. Subscribe Revenue Network segment continues to struggle, but the rest of the businesses

Sartorius Stedim: A Pure-play Pick-and-Shovel in Biotech

Disclosure: I own Preference Shares of Sartorius AG You can listen to this Deep Dive here In 1870, Florenz Sartorius, at the age of 24, founded Sartorius which was primarily a manufacturer of analytical balances in Germany. By late 1800s, in addition to balances, Sartorius expanded its operations to incubators

Why I am buying CoStar Group

I have started a ~3% position in CoStar (CSGP) at $71/share and would like to increase the position to ~5% if the stock goes down to ~$60. I wrote a Deep Dive on CSGP back in January 2024, so I would suggest reading my Deep Dive for a more

Buying Puts on QQQ

I posted on X and Threads yesterday why I started buying some puts on QQQ. Since not all of my readers may be on X and Threads, let me share my thoughts with you as well. I have also edited a bit and expanded on a couple of points after

July, 2024 Update

Just a very short update for this month. I will publish a Deep Dive on Sartorius Stedim Biotech by 25th of this month. After studying IQVIA last month, I am enjoying working on some healthcare companies and may choose to do a couple more this year to keep extending my

IQVIA Deep Dive

Note: I recorded the audio version of this Deep Dive, but unfortunately the file got corrupted and for some reason, it has randomly deleted 20 minutes of the final version. So, you won’t be able to listen to this month’s Deep Dive. Apologies for the inconvenience. Back in

Lululemon 1Q'24 Update

Disclosure: I own January 2026 $165 LULU Call Options Lululemon was facing some really thorny questions from Mr. Market ever since 4Q’23 earnings. Today’s earnings should help calm some nerves. Here are my highlights from tonight’s call. Sales Growth by Region At first glance, one may find